Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)?
- PMID: 35074935
- PMCID: PMC8975055
- DOI: 10.1681/ASN.2021121550
Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)?
Keywords: apheresis; guidelines; randomized controlled trials; shared decision making.
Comment on
-
Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.J Am Soc Nephrol. 2022 Mar;33(3):628-637. doi: 10.1681/ASN.2021060771. Epub 2022 Jan 24. J Am Soc Nephrol. 2022. PMID: 35074934 Free PMC article.
References
-
- Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. : 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol 73: 1366–1383, 2021 - PubMed
-
- Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group : KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Available at: https://kdigo.org/guidelines/. Accessed September 22, 2021
-
- Balogun RA, Sanchez AP, Klingel R, Witt V, Aqui N, Meyer E, et al. : Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis. J Clin Apher 35: 493–499, 2020 - PubMed
-
- Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. ; European Vasculitis Study Group : Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18: 2180–2188, 2007 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources